Y
Yoshikazu Nishi
Researcher at Hiroshima University
Publications - 89
Citations - 1489
Yoshikazu Nishi is an academic researcher from Hiroshima University. The author has contributed to research in topics: Growth hormone deficiency & Pituitary gland. The author has an hindex of 19, co-authored 89 publications receiving 1438 citations.
Papers
More filters
Journal ArticleDOI
The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma.
Kazunori Arita,Fusao Ikawa,Kaoru Kurisu,Masayuki Sumida,Kunyu Harada,Tohru Uozumi,Shuji Monden,Jun Yoshida,Yoshikazu Nishi +8 more
TL;DR: In this paper, the authors classified 11 cases of hypothalamic hamartoma into two categories based on the magnetic resonance (MR) imaging characteristics and the patient's clinical symptoms, but the relationship between the neuroradiological findings and clinical presentation has never been fully investigated.
Journal ArticleDOI
Neonatal Diabetes Mellitus and Neonatal Polycystic, Dysplastic Kidneys: Phenotypically Discordant Recurrence of a Mutation in the Hepatocyte Nuclear Factor-1β Gene Due to Germline Mosaicism
Tohru Yorifuji,Keiji Kurokawa,Mitsukazu Mamada,Tsuyoshi Imai,Masahiko Kawai,Yoshikazu Nishi,Seiichiro Shishido,Yukihiro Hasegawa,Tatsutoshi Nakahata +8 more
TL;DR: Recurrence of a novel missense mutation in the HNF-1beta gene, S148W (C443G), in two sibs, one with neonatal diabetes mellitus and the other with Neonatal polycystic, dysplastic kidneys leading to early renal failure are described.
Journal ArticleDOI
Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan
Yoshikazu Nishi,Toshiaki Tanaka,Kazue Takano,Kenji Fujieda,Yutaka Igarashi,Kunihiko Hanew,Takeki Hirano,Susumu Yokoya,Katsuhiko Tachibana,Tomohiro Saito,Shaw Watanabe +10 more
TL;DR: It is concluded that the incidence of leukemia in GH-treated patients without risk factors is not greater than that in the general population aged 0-15 yr, and a possible increased occurrence of leukemia with GH treatment appears to be limited to patients with risk factors.
Journal ArticleDOI
Zinc, copper, manganese, and selenium metabolism in thyroid disease.
Katsuaki Aihara,Yoshikazu Nishi,Shuichi Hatano,Mikio Kihara,Kazunori Yoshimitsu,Nobuo Takeichi,Toshio Ito,Haruo Ezaki,Tomofusa Usui +8 more
TL;DR: The results of this study suggest that the metabolism of zinc, copper, manganese, and selenium is abnormal in thyroid diseases.
Journal ArticleDOI
Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height.
Yukihiro Hasegawa,Katsura Fujii,Makoto Yamada,Yutaka Igarashi,Katsuhiko Tachibana,Toshiaki Tanaka,Kazumichi Onigata,Yoshikazu Nishi,Shigeaki Kato,Tomonobu Hasegawa +9 more
TL;DR: It is indicated that GH secretion is partially determined by polymorphisms in the GH-1 gene, which explain some of the variations in GH secretion and Ht.